BEGIN:VCALENDAR
VERSION:2.0
PRODID:Linklings LLC
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
X-LIC-LOCATION:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20241017T183512Z
LOCATION:Harbor Ballroom A
DTSTART;TZID=America/Los_Angeles:20241017T093500
DTEND;TZID=America/Los_Angeles:20241017T095500
UID:ncs_NCS 2024_sess110_ccrnt148@linklings.com
SUMMARY:Practical Interventions using Novel Neurologic AI for Clinical Equ
 ity: The PINNACLE of Neurocritical Care
DESCRIPTION:Breakout Session\n\nKara Melmed (NYU Grossman School of Medici
 ne)\n\nI propose to discuss how to harness the power of AI to decrease loc
 al and global disparities in Neurocritical Care. As research accumulates d
 emonstrating the burden of inequitable care in Neurocritical Care, we need
  to refocus our attention on ameliorating the disparities.  One practical 
 way to achieve this goal is to use existing and forthcoming AI technology 
 to ensure fairness and equity. This talk will discuss action items to miti
 gate disparities locally, national and globally.  I will cover current and
  future technologies such as automated TCD interpretations, global use of 
 portable and low tesla MRI, AI augmented robot assisted surgeries such as 
 thrombectomy, automated language translation for acute neurologic care, an
 d follow up augmented assistance to families for diminishing burden such a
 s virtual medication assistance and compliance.  Finally I will discuss th
 e pitfalls and potential bias that is inherent to AI that also might accen
 tuate disparities.\n\nTrack: Delivery, Quality and Safety\n\nFocus Area: A
 PP Practice, Diversity, Equity, and Inclusion, Global Neurocritical Care, 
 Informatics, Patient Education, Provider Education Topics (eg fellowship t
 raining, competency assessment, etc)\n\nTarget Audience: Introductory, Int
 ermediate\n\nSession Chair: Cássia Shinotsuka (Instituto Estadual do Céreb
 ro, Instituto Nacional de Infectologia)
END:VEVENT
END:VCALENDAR